NAPPI, ANNA GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 354
EU - Europa 173
AS - Asia 67
OC - Oceania 1
SA - Sud America 1
Totale 596
Nazione #
US - Stati Uniti d'America 354
SE - Svezia 60
IT - Italia 45
CN - Cina 24
SG - Singapore 23
GB - Regno Unito 15
BE - Belgio 12
DE - Germania 12
FR - Francia 6
IN - India 6
VN - Vietnam 5
NL - Olanda 4
AT - Austria 3
CZ - Repubblica Ceca 3
IR - Iran 3
PH - Filippine 3
UA - Ucraina 3
FI - Finlandia 2
NO - Norvegia 2
RU - Federazione Russa 2
BD - Bangladesh 1
BR - Brasile 1
DK - Danimarca 1
IE - Irlanda 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 596
Città #
Chandler 90
Nyköping 44
Ashburn 30
Fairfield 21
Singapore 19
Brussels 12
Modugno 11
Ann Arbor 10
Lawrence 10
Roxbury 10
Seattle 10
Beijing 8
Dearborn 8
Des Moines 8
Houston 8
Woodbridge 7
Inglewood 6
Cambridge 5
Dong Ket 5
Pune 5
Washington 5
Brooklyn 4
Eelde 4
Leawood 4
New York 4
San Mateo 4
Wilmington 4
Brno 3
General Mariano Alvarez 3
Los Angeles 3
Ostuni 3
Paris 3
Santa Clara 3
Suffolk 3
Ardabil 2
Augusta 2
Bari 2
Brindisi 2
Falls Church 2
Helsinki 2
Jinhua 2
Lienz 2
Munich 2
Radal 2
Reggio Calabria 2
Sheffield 2
Villa Cortese 2
Altamura 1
Auckland 1
Changsha 1
Chisinau 1
Chiswick 1
Copenhagen 1
Dallas 1
Dhaka 1
Dhankutā 1
Dublin 1
Edinburgh 1
Frankfurt am Main 1
Frattamaggiore 1
Fuzhou 1
Hebei 1
Hounslow 1
Jiaxing 1
Jinan 1
Macao 1
Moscow 1
Nanchang 1
Norwalk 1
San Diego 1
San Francisco 1
Shanghai 1
Shaoxing 1
São Paulo 1
Taranto 1
Tehran 1
Vienna 1
Warsaw 1
Wuhan 1
Wuxi 1
Totale 436
Nome #
How often suspected pulmonary embolism is diagnosed and its main diagnostic characteristics, in an emergency nuclear medicine service? Four years experience 77
THE PALEORADIOLOGY IMPORTANCE IN THE STUDY OF RELICS: THE UNIQUE DENSITOMETRIC ANALYSIS OF A BONE RELIC OF SAINT NICHOLAS 75
The Lymphoscintigraphic Study of Unpredictable Head and Neck Cutaneous Melanoma Lymphatic Drainage 67
Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging 59
Typical and atypical PET/CT findings in non-cancerous conditions 53
The day after mass COVID-19 vaccination: incidence of vaccine-related lymphadenopathy PET and impact on oncologic patients management 51
Is whole body low dose CT still necessary in the era of 18F-FDG PET/CT for the assessment of bone disease in multiple myeloma patients? 48
null 47
Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis 44
Sickle cell diseases: What can nuclear medicine offer? 37
Early evaluation of immunotherapy response in lymphoma patients by 18f-fdg pet/ct: A literature overview 35
18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients 17
[18F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients 14
[18F]FDG PET/CT in head and neck squamous cell carcinoma: a head-to-head between visual point-scales and the added value of multi-modality imaging 13
Intracranial Solitary Fibrous Tumor: A “New” Challenge for PET Radiopharmaceuticals 11
The role of oropharyngoesophageal scintigraphy in the assessment of dysphagia in neurological patients 11
Prevalence and clinical impact of incidental findings on the unenhanced CT images of PET/CT scan in patients with multiple myeloma: the value of radiological reporting in the multimodal hybrid imaging 7
Totale 666
Categoria #
all - tutte 4.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.163


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 3 0 8 5 3 0 4 11 0
2020/2021108 3 2 0 20 22 6 6 15 4 7 18 5
2021/2022113 7 7 1 8 10 21 3 6 2 4 17 27
2022/2023232 27 38 13 15 16 19 14 30 39 4 7 10
2023/2024113 7 17 9 12 14 31 2 0 0 9 0 12
2024/202557 23 11 22 1 0 0 0 0 0 0 0 0
Totale 666